Here, we describe generation of specific canine PD-1 and PD-L1 monoclonal antibodies and validation in canine apocrine gland anal sac adenocarcinoma (AGASACA), a previously identified tumor characterized by aberrant immune checkpoint activation. This evidence concerns the gene CD274 and neoplasm.